Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Viruses ; 12(6)2020 05 31.
Article in English | MEDLINE | ID: mdl-32486454

ABSTRACT

: Grapevine line pattern virus (GLPV) was first described 30 years ago in Hungary. The lack of its genomic sequences and of an available antiserum made its detection impossible in other parts of the world. Three different high-throughput sequencing (HTS) protocols applied on a GLPV-infected vine allowed the construction of the full genome sequence of this virus. It includes three RNA segments, encoding four proteins: methyltransferase-helicase (1a), RNA-dependent RNA polymerase (2a), movement protein (3a) and coat protein (3b). The obtained sequences were used to design specific primers for its detection by RT-PCR and Northern blot hybridization, respectively. These diagnostic methods were used to test the presence of GLPV in graft-inoculated plants and in 220 grapevine accessions of different Mediterranean origins. The three RNAs-encoding proteins of GLPV shared a very high amino acid identity with those of hop yellow virus, a tentative member of the Anulavirus genus, leaving no doubt that both are two isolates of the same viral species. A circular RNA originating from the RNA2 was found, for which an alternative silencing suppressor role is hypothesized. Further investigation is needed to determine this possibility and also the host range and pathological significance of the virus.


Subject(s)
Bromoviridae/genetics , Genome, Viral/genetics , Plant Diseases/virology , Vitis/virology , Blotting, Northern , Phylogeny , RNA, Circular/genetics , RNA, Viral/genetics , Sequence Analysis, DNA
2.
Otolaryngol Head Neck Surg ; 136(5): 783-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17478216

ABSTRACT

OBJECTIVE: To describe clinical features of high-grade (HG) mucoepidermoid carcinoma (MEC) of the parotid gland and assess clinical outcomes of one surgical management approach. DESIGN/SETTING/METHODS: Retrospective case series in a tertiary care academic institution. Pathology records were reviewed from 1977 to 1997, identifying patients with parotid HG MEC. Available medical records were reviewed for data on clinical features, treatment, and outcome. RESULTS: Increased stage, increased T stage, presence of neck metastasis, and distant metastasis were all associated with poor outcome. Wide local excision and postoperative radiation (XRT) provided 82% local control. XRT alone for N0 disease provided 86% regional control, while XRT and neck dissection yielded 74% control in N(+) cases. CONCLUSION: High-grade MEC of the parotid gland is an aggressive disease that frequently presents at advanced stage. Parotidectomy with modified radical neck dissection and postoperative XRT provides reasonable local and regional control for patients with N(+) disease. Elective selective neck dissection and radiation should be considered for T3 and T4 tumors with N0 status.


Subject(s)
Carcinoma, Mucoepidermoid/pathology , Carcinoma, Mucoepidermoid/surgery , Neoplasm Staging , Parotid Neoplasms/pathology , Parotid Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Carcinoma, Mucoepidermoid/complications , Facial Nerve Diseases/etiology , Facial Nerve Diseases/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neck Dissection , Parotid Neoplasms/complications , Retrospective Studies , Treatment Outcome
3.
Cancer ; 104(7): 1418-27, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-16116597

ABSTRACT

BACKGROUND: Amifostine was developed to protect normal tissues from radiation exposure. The current study was undertaken to determine whether amifostine would allow the delivery of greater numbers of weekly paclitaxel treatments with concomitant, hyperfractionated radiotherapy in patients with advanced head and neck carcinoma. METHODS: Patients received radiation therapy twice daily using 1.6-gray (Gy) fractions up to a total of 70.4 Gy over an elapsed time of 6.5 weeks. All patients received paclitaxel 60 mg/m(2) once weekly starting on Day 1. The number of doses of paclitaxel was escalated from three to a maximum of six in groups of three patients. For the patients who received amifostine, a dose of 400 mg/m(2) was given intravenously over 15 minutes on Days 1-5, 8, 29-33, and 36. Patients underwent surgery for persistent tumor after radiotherapy. The plasma pharmacokinetics of paclitaxel were characterized during treatment with the first weekly dose to determine the effect of concurrently administered amifostine. RESULTS: Thirty-six patients were evaluable for this study. In the absence of amifostine, a maximum of four doses of paclitaxel were tolerated in combination with the radiotherapy. With amifostine, up to five doses of paclitaxel could be given. Generally, the treatment resulted in Grade 2 and 3 stomatitis. Overall, 69% of patients had a complete remission, and 29% had a partial remission. Both progression-free survival and overall survival were 66% at 30 months. Amifostine had no effect on the pharmacokinetics of paclitaxel. CONCLUSIONS: The administration of amifostine allowed the authors to give an additional dose of paclitaxel to patients who were undergoing hyperfractionated radiotherapy for head and neck carcinoma. This treatment regimen resulted in a high frequency of complete remissions and an excellent progression-free survival pattern without compromising the plasma kinetics of paclitaxel.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics , Carcinoma, Squamous Cell/therapy , Head and Neck Neoplasms/therapy , Neoplasm Invasiveness/pathology , Amifostine/pharmacokinetics , Amifostine/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Combined Modality Therapy , Dose Fractionation, Radiation , Female , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/pathology , Humans , Male , Maximum Tolerated Dose , Neoplasm Staging , Paclitaxel/pharmacokinetics , Paclitaxel/therapeutic use , Probability , Prognosis , Radiotherapy Dosage , Radiotherapy, Adjuvant , Risk Assessment , Survival Rate , Treatment Outcome
4.
Laryngoscope ; 115(1): 101-4, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15630376

ABSTRACT

INTRODUCTION: Free tissue transfer has become the primary reconstructive modality for significant ablative defects in the head and neck. The overall success rate is high, approaching 95% in most centers. The success rate of multiple sequential free flaps has been thought to be lower, based on the absence of optimal vessel availability and the presence of significant scar tissue in the previously operated patient. We evaluated a series of patients who underwent multiple free flaps at different time points to determine the overall success rate and to identify pitfalls encountered in this population. METHODS: Retrospective review, tertiary care medical center. RESULTS: From 1995 to 2002, 377 free flaps were performed by our reconstructive service. Of this group, 36 underwent multiple free flaps at different time points. Thirty-two had two flaps, and four had three flaps. Reasons for performing sequential free flap procedures were as follows: recurrent disease/new primary (18), need for further augmentation (10), failed previous flap (6), delayed mandibular reconstruction after plate fracture (2), mandibular osteoradionecrosis (3), and delayed pharyngoesophageal stenosis (1). The overall failure rate on the second and third flap was 2 of 32 and 0 of 4, respectively, with an overall success rate of 94%. CONCLUSION: Multiple, sequential, free tissue transfer for reconstruction of head and neck defects is a safe and reliable procedure with success rates equal to that in patients undergoing initial free flap reconstruction. Careful preoperative planning can result in optimal outcomes even in this difficult patient population.


Subject(s)
Head and Neck Neoplasms/surgery , Plastic Surgery Procedures , Surgical Flaps , Adult , Aged , Aged, 80 and over , Female , Graft Survival , Humans , Male , Middle Aged , Reoperation
5.
Arch Otolaryngol Head Neck Surg ; 130(8): 923-8, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15313861

ABSTRACT

BACKGROUND: Confocal reflectance microscopy (CRM) is an optical method of imaging tissue noninvasively without the need for fixation, sectioning, and staining as in standard histopathologic analysis. Image contrast is determined by natural differences in refractive indices of organelles and other subcellular structures within the tissues. Gray-scale images are displayed in real time on a video monitor and represent horizontal (en face) optical sections through the tissue. We hypothesized that CRM is capable of discerning histologic characteristics of different tissues in the head and neck. OBJECTIVES: To examine the microscopic anatomy of freshly excised head and neck surgical specimens en bloc using CRM and to compare the findings with those generated by conventional histologic analysis. DESIGN: This was a pilot observational cohort study. Bone, muscle, nerve, thyroid, parotid, and ethmoid mucosa from human surgical specimens were imaged immediately after excision. Confocal images were compared with corresponding routine paraffin-embedded, hematoxylin-eosin-stained sections obtained from the same tissue. RESULTS: Characteristic histologic features of various tissues and cell types were readily discernible by CRM and correlated well with permanent sections. However, in all tissues examined, there was less microscopic detail visible in the CRM images than was appreciated in paraffin-embedded histologic sections. CONCLUSIONS: The CRM images revealed cytologic features without the artifacts of histologic processing and thus may have the potential for use as an adjunct to frozen-section analysis in intraoperative consultation.


Subject(s)
Head/surgery , Image Enhancement , Neck/surgery , Cohort Studies , Coloring Agents , Connective Tissue/anatomy & histology , Connective Tissue/pathology , Eosine Yellowish-(YS) , Head/pathology , Hematoxylin , Humans , Microscopy, Confocal , Muscle, Skeletal/anatomy & histology , Muscle, Skeletal/pathology , Musculocutaneous Nerve/anatomy & histology , Musculocutaneous Nerve/pathology , Myelin Sheath , Nasal Mucosa/anatomy & histology , Nasal Mucosa/pathology , Neck/pathology , Parotid Gland/anatomy & histology , Parotid Gland/pathology , Pilot Projects , Thyroid Gland/anatomy & histology , Thyroid Gland/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...